In a panel of melanoma cells, the dual LSD1/HDAC compound Corin (Figure 6) (Kalin et al., 2018) exhibited higher inhibition of proliferation with respect to the relative single-target inhibitors (TCP for LSD1 and Entinostat for HDACs) and to their combination. This evidence concerns the gene KDM1A and melanoma.